Study of NPO-13 During Colonoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

March 26, 2020

Study Completion Date

March 26, 2020

Conditions
Bowel Disease
Interventions
DRUG

NPO-13: l-menthol

20 mL/site

Trial Locations (13)

Unknown

NPO-13 Trial Site 11, Kitakyushu

NPO-13 Trial Site 12, Kurume

NPO-13 Trial Site 2, Maebashi

NPO-13 Trial Site 5, Yokohama

NPO-13 Trial Site 6, Yokohama

NPO-13 Trial Site 1, Shimotsuke

NPO-13 Trial Site 4, Minato

NPO-13 Trial Site 3, Shinjuku

NPO-13 Trial Site 9, Hiroshima

NPO-13 Trial Site 13, Kagoshima

NPO-13 Trial Site 10, Kochi

NPO-13 Trial Site 7, Osaka

NPO-13 Trial Site 8, Osaka

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY